Your cart
Your cart is empty.HEALTH NEWS
Study Title:
Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barr
Study Abstract
Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barrier Damage through Adenosine Monophosphate-Activated Protein Kinase/Silent Information Regulator 1/Nuclear Factor Kappa-B Signaling Pathways in Caco-2 Cells.
Study Information
Int J Mol Sci. 2023 Oct 19;24(20):15337. doi: 10.3390/ijms242015337. PMID: 37895018; PMCID: PMC10607795.
Full Study
https://pubmed.ncbi.nlm.nih.gov/37895018/
JANUARY SALE
Curb cravings, energize metabolism, and reach your goals in 2025!